Uncategorized

2024 began with several biopharma players posting positive Phase III data that could mean new market share for the companies and longer survival times and quality of life for patients.

Researchers are working to optimize the properties of antibody-drug conjugates in order to maximize clinical efficacy while minimizing the risk of toxicities.

With second-generation antibody-drug conjugates, Eli Lilly, Daiichi Sankyo and others look to reduce toxicity and improve the magnitude and duration of response.

Helix Biostructures offers a full gene-to-structure suite of cryo-EM services that focuses on both quality and fast turnaround/throughput.

Revisión de la anatomía y función básica de la laringe, los síntomas de la patología de las cuerdas vocales y las pautas actuales de manejo clínico

Los trabajos destacados de un encuentro de relevancia mundial

The approvals, third line for BMS and 2seventy Bio’s Abecma and second line for J&J and Legend Biotech’s Carvykti, represent a new class of therapy for these blood cancer patients.

El sector de los juegos de casino sigue creciendo con tecnología innovadora y juegos envolventes, pero también suele percibirse únicamente como un lugar de azar y entretenimiento. Sin embargo, hay mucho más en este sector, sobre todo si nos centramos en el área de …

Cowen analysts said Freenome’s results are good news for competitors Exact Sciences and Guardant Health.

A management shakeup is likely coming at the right time, as the virtual care company undergoes an operational review to boost its bottom line, analysts said.